Kinases as Drug Discovery Targets in Hematologic Malignancies

E-ISSN： 1875-5666|5|7|625-642

ISSN： 1566-5240

Source： Current Molecular Medicine, Vol.5, Iss.7, 2005-11, pp. : 625-642

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Angiogenesis in hematologic malignancies

By Moehler T. Neben K. Ho A. Goldschmidt H.

Annals of Hematology, Vol. 80, Iss. 12, 2001-12 ,pp. : 695-705

Springer Publishing Company

Access to resources Recommend Favorite

Apoptosis-regulating proteins as targets for drug discovery

By Reed J.C.

Trends in Molecular Medicine, Vol. 7, Iss. 7, 2001-07 ,pp. : 314-319

Elsevier

Access to resources Recommend Favorite

Serine Kinases as New Drug Targets for the Treatment of Type 2 Diabetes

Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents, Vol. 5, Iss. 6, 2005-12 ,pp. : 529-536

Bentham Science Publishers

Access to resources Recommend Favorite

Intrathecal chemotherapy for hematologic malignancies: drugs and toxicities

By Kwong Yok-Lam

Annals of Hematology, Vol. 88, Iss. 3, 2009-03 ,pp. : 193-201

Springer Publishing Company

Access to resources Recommend Favorite

Hematologic malignancies associated with germ cell tumors

By Zhao Guang-Quan Dowell Jonathan E

Expert Review of Hematology, Vol. 5, Iss. 4, 2012-08 ,pp. : 427-437

Informa Healthcare

Access to resources Recommend Favorite